Benaka Meditech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 20-12-2024
- Paid Up Capital ₹ 1.00 M
as on 20-12-2024
- Company Age 7 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.01 M
as on 20-12-2024
- Revenue 4.35%
(FY 2022)
- Profit 102.82%
(FY 2022)
- Ebitda 105.23%
(FY 2022)
- Net Worth 73.59%
(FY 2022)
- Total Assets 1.55%
(FY 2022)
About Benaka Meditech
The Company is engaged in the Engineering Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.01 M.
Vishnu Hebbar and Ashwini Hebbar serve as directors at the Company.
- CIN/LLPIN
U51909KA2017PTC106842
- Company No.
106842
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Sep 2017
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Benaka Meditech Private Limited offer?
Benaka Meditech Private Limited offers a wide range of products and services, including Forceps & Graspers, Surgical Pendant, PVC, CPVC, HDPE Water Pipe Fittings, Pipe Saddles, Surgical & ICU Equipments, ICU Equipments, Electrical Panels & Distribution Box, Industrial Control Panel, Hospital and Medical Furniture, Hospital Equipment.
Who are the key members and board of directors at Benaka Meditech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishnu Hebbar  | Director | 29-Sep-2017 | Current |
| Ashwini Hebbar | Director | 29-Sep-2017 | Current |
Financial Performance of Benaka Meditech.
Benaka Meditech Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.35% increase. The company also saw a substantial improvement in profitability, with a 102.82% increase in profit. The company's net worth Soared by an impressive increase of 73.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Benaka Meditech?
In 2022, Benaka Meditech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 02 Mar 2023 | ₹2.01 M | Open |
How Many Employees Work at Benaka Meditech?
Unlock and access historical data on people associated with Benaka Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Benaka Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Benaka Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
